感染性疾病分子诊断管理计划的开发与实施方法:ASM实验室实践小组报告
该报告由ASM实验室实践小组撰写,针对感染性疾病分子微生物学检测的快速增长与复杂性,提出建立多学科诊断管理(DxS)团队的建议。报告详述了识别需评估的高优先级检测、选择诊断管理干预措施及监测干预效果的方法,以优化检测使用并减少资源浪费。
要点
- 建立包含微生物学家及检测使用方的多学科DxS团队
- 识别需利用评估的高优先级分子微生物学检测
- 选择并监测诊断管理干预措施对检测使用的影响
核心结论
- 实验室可采用该策略流程实现所选检测的优化使用。
研究设计与样本
- ASM实验室实践小组报告(综述),总结建立协作DxS团队及实施干预的方法。
主要发现
- 分子微生物学检测在过去二十年快速扩展,需协作优化使用以促进患者获益并减少资源浪费。
临床怎么用
- 实验室可组建多学科DxS团队,识别高优先级检测,实施并监测诊断管理干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diagnostic stewardship (DxS) for infectious disease testing requires a multi-disciplinary approach to optimize test selection, performance, interpretation and patient treatment. Nucleic acid amplification-based tests for the diagnosis of infectious diseases, or "molecular microbiology tests," have rapidly expanded over the past two decades. With the increased availability and complexity of these tests, there is also an increased need for collaborative approaches to optimize test use to promote positive impacts on patient care, while mitigating potential negative impact or resource waste. In this review, we provide recommendations on building collaborative DxS teams, including microbiologists and the diverse stakeholders that use and interpret molecular microbiology tests. We then detail approaches to identify high-priority molecular microbiology tests that may need utilization assessment, select appropriate diagnostic stewardship interventions, and monitor the impact of implemented interventions. This strategic process may be employed by laboratories to realize optimal testing for selected tests at their institution.
引用
- Valencia-Shelton F, Anderson N, Palavecino EL, et al. Approaches to developing and implementing a molecular diagnostics stewardship program for infectious diseases: an ASM Laboratory Practices Subcommittee report. J Clin Microbiol. 2024. PMID: 39431829. doi:10.1128/jcm.00941-24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。